Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks.
CAS Number:
[1582205-90-0]
Target:
AMG-334
* VAT and and shipping costs not included. Errors and price changes excepted